Ubs Oconnor LLC En V Veno Medical Corp Transaction History
Ubs Oconnor LLC
- $1.72 Billion
- Q2 2024
A detailed history of Ubs Oconnor LLC transactions in En V Veno Medical Corp stock. As of the latest transaction made, Ubs Oconnor LLC holds 230,790 shares of NVNO stock, worth $784,686. This represents 0.07% of its overall portfolio holdings.
Number of Shares
230,790Holding current value
$784,686% of portfolio
0.07%Shares
10 transactions
Others Institutions Holding NVNO
# of Institutions
32Shares Held
3.73MCall Options Held
98.5KPut Options Held
6.1K-
Kingdon Capital Management, L.L.C. New York, NY654KShares$2.22 Million0.4% of portfolio
-
Perceptive Advisors LLC New York, NY623KShares$2.12 Million0.09% of portfolio
-
Vanguard Group Inc Valley Forge, PA589KShares$2 Million0.0% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT478KShares$1.62 Million0.17% of portfolio
-
Act Capital Management, LLC Wayne, PA401KShares$1.36 Million3.48% of portfolio
About enVVeno Medical Corp
- Ticker NVNO
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 9,469,850
- Market Cap $32.2M
- Description
- enVVeno Medical Corporation, a medical device company, focuses on the development of various bioprosthetic tissue-based solutions to enhance the standard of care in the treatment of venous diseases. The company's lead product is the VenoValve, a surgical implant being developed for the treatment of severe deep venous chronic venous insufficiency...